Cargando…
Subanesthetic ketamine for pain management in hospitalized children, adolescents, and young adults: a single-center cohort study
BACKGROUND: Subanesthetic doses of ketamine, an N-methyl-d-aspartate receptor antagonist used as an adjuvant to opioid for the treatment of pain in adults with acute and chronic pain, have been shown, in some instances, to improve pain intensity and to decrease opioid intake. However, less is known...
Autores principales: | Sheehy, Kathy A, Lippold, Caroline, Rice, Amy L, Nobrega, Raissa, Finkel, Julia C, Quezado, Zenaide MN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388303/ https://www.ncbi.nlm.nih.gov/pubmed/28435316 http://dx.doi.org/10.2147/JPR.S131156 |
Ejemplares similares
-
Subanesthetic ketamine infusions for the treatment of children and adolescents with chronic pain: a longitudinal study
por: Sheehy, Kathy A., et al.
Publicado: (2015) -
Resurfacing of ketamine: The subanesthetic paradigm
por: Ramachandran, Rashmi, et al.
Publicado: (2016) -
Neuregulin signaling mediates the acute and sustained antidepressant effects of subanesthetic ketamine
por: Grieco, Steven F., et al.
Publicado: (2021) -
Resting-state brain functional connectivity in patients with chronic pain who responded to subanesthetic-dose ketamine
por: Motoyama, Yasushi, et al.
Publicado: (2019) -
Ischemic Postconditioning and Subanesthetic S(+)-Ketamine Infusion: Effects on Renal Function and Histology in Rats
por: de Resende, Marco A. C., et al.
Publicado: (2015)